Axonics. has been granted a patent for a system and method that utilizes X-ray imaging to assist in the placement of peripheral nerve evaluation leads. The apparatus includes a guiding mechanism with indicia for accurate needle insertion during sacral nerve stimulation therapy. GlobalData’s report on Axonics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Axonics, Neuromodulation implants was a key innovation area identified from patents. Axonics's grant share as of July 2024 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
Needle insertion guidance for sacral nerve stimulation therapy
The patent US12064139B2 describes an innovative apparatus designed to assist healthcare professionals in the precise insertion of a needle for sacral nerve stimulation therapy. The apparatus features an elongated base that extends longitudinally along the patient's back, with a depending portion that rests against the coccyx. This base is equipped with a first set of indicia to guide the insertion process. A lateral member, which is slidably attached to the base, includes a second set of indicia and is designed to facilitate the alignment of the needle at a predetermined angle. Additionally, the apparatus incorporates an element guide that aids in directing the needle to the target location, enhancing the accuracy of the procedure.
Further enhancements to the apparatus include an adjustable needle guide and a radiopaque locating element that can be selectively attached to the base for improved visibility during imaging. The guide body, which is also slidably attached to the lateral member, features multiple grooves and angled openings to provide various pathways for needle insertion, ensuring that the needle can be directed to the target location at the desired angle. The design includes specific measurements and reference lines to assist in achieving the correct insertion depth and angle, thereby optimizing the effectiveness of sacral nerve stimulation therapy while minimizing potential complications.
To know more about GlobalData’s detailed insights on Axonics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
